Nice list, mate.
My wish list is as follows:
1. Immunotherapy umbrella trial in all cancer types and at least Keytruda and opdivo
Here is the approved indications for Keytruda:
Breast, Melanoma, NSCLC, DMMR/MSI-H Metastatic Solid, Head And Neck Squamous Cell, Urothelial, Colon, Rectal, Esophageal, Certain Gastroesophageal Junction, Cervical, Renal Cell, Endometrial And Cutaneous Squamous Cell
Here is the approved indications for Opdivo:
Melanoma, NSCLC, SCLC, Malignant Pleural Mesothelioma, Renal Cell, Hodgkin Lymphoma, Head And Neck Squamous Cell, Urothelial, DMMR/MSI-H Metastatic Colorectal, Hepatocellular, Esophageal, Gastric And Gastroesophageal Junction
There is a lot of crossover there.
2. Targeted therapy umbrella trial in major earners for each class
- Some of the highest earning targeted therapies with the greatest number of indication approvals are focused on HER2, VEGF, VEGFR, BRAF/MEK, CTLA-4, and BTK.
- Bisantrene has already demonstrated excellent synergy with VEGFR and BRAF/MEK inhibitors, so maybe they will be the focus.
I generally don't think a single cancer approach will be a smart move by RAC to maximise value in the shortest time possible. Therefore, trials that include a wide range of cancer types demonstrates that this is not a one cancer drug and is in fact a broad acting, broadly synergistic molecule.
- Forums
- ASX - By Stock
- RAC
- Speculative M&A Transaction Analysis
Speculative M&A Transaction Analysis, page-771
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.66 |
Change
-0.020(1.19%) |
Mkt cap ! $282.8M |
Open | High | Low | Value | Volume |
$1.68 | $1.68 | $1.61 | $118.5K | 72.33K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 601 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.650 |
1 | 276 | 1.630 |
1 | 2000 | 1.625 |
2 | 1025 | 1.620 |
1 | 3000 | 1.615 |
Price($) | Vol. | No. |
---|---|---|
1.660 | 601 | 1 |
1.700 | 6382 | 1 |
1.720 | 580 | 1 |
1.730 | 309 | 1 |
1.735 | 609 | 1 |
Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |